Package Leaflet: Information for the User
Lefluartil 10 mg film-coated tablets EFG
Leflunomide
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Lefluartil belongs to a group of medicines called antirheumatic medicines.
Lefluartil is used to treat adult patients with active rheumatoid arthritis or active psoriatic arthritis.
The symptoms of rheumatoid arthritis include joint inflammation, swelling, difficulty moving, and pain. Other symptoms that affect the whole body include loss of appetite, fever, lack of energy, and anemia (reduction in the number of red blood cells in the blood).
The symptoms of active psoriatic arthritis include joint inflammation, swelling, difficulty moving, pain, red-colored plaques, and scaly skin (skin lesions).
Do not take Lefluartil
if you have any liver problem,
if you have a severe infection,
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting treatment with Lefluartil:
Males who wish to have children should contact their doctor, who may advise them to discontinue treatment with Lefluartil and take certain medications to rapidly and sufficiently eliminate Lefluartil from their body. In this case, a blood test will be necessary to ensure that Lefluartil has been sufficiently eliminated from their body, and then they should wait at least 3 months before trying to have children.
Occasionally, Lefluartil may cause some problems in the blood, liver, lungs, or nerves of the arms or legs. It may also cause some severe allergic reactions (including drug rash with eosinophilia and systemic symptoms [DRESS syndrome]) or increase the risk of serious infections. For more information on these side effects, see section 4 (Possible side effects).
DRESS syndrome initially appears with symptoms similar to those of the flu and a skin rash on the face, followed by a widespread skin rash with fever, elevated liver enzyme levels in the blood, and an increase in a type of white blood cell (eosinophilia) and enlarged lymph nodes.
Your doctor will perform blood testsat regular intervals, before and during treatment with Lefluartil, to monitor blood cells and liver function. Your doctor should also regularly check your blood pressure, as Lefluartil may cause an increase in blood pressure.
Consult your doctor if you experience chronic diarrhea of unknown origin. You may need to undergo additional tests to establish a differential diagnosis.
Inform your doctor if you develop a skin ulcer during treatment with Lefluartil (see section 4).
Use in children:
Lefluartil is not recommended for use in children and adolescents under 18 years of age.
Use of other medicines
Inform your doctor or pharmacist if you are using or have recently used other medicines, even those obtained without a prescription.
This is especially important if you are taking:
If you are taking a non-steroidal anti-inflammatorymedicine (NSAIDs) and/or corticosteroids, you may continue taking them after starting treatment with Lefluartil.
Vaccinations
Consult your doctor if you need to be vaccinated. Some vaccines cannot be administered while you are being treated with Lefluartil or for a certain period after stopping treatment.
Taking Lefluartil with food and drinks
Lefluartil can be taken with or without food.
It is not recommended to consume alcohol during treatment with Lefluartil. Alcohol consumption during treatment with Lefluartil may increase the risk of liver damage.
Pregnancy and breastfeeding
Do not takeLefluartil if you are or think you may be pregnant. Women of childbearing age should not take Lefluartil without using effective contraceptive measures.
Inform your doctor if you plan to become pregnant after stopping treatment with Lefluartil, as it is necessary to ensure that there are no remaining amounts of Lefluartil in your body before becoming pregnant. The elimination of the medicine from the body may take up to 2 years. This time period can be reduced to a few weeks by taking certain medicines that accelerate the elimination of Lefluartil from the body. In any case, before becoming pregnant, a blood test should be performed to confirm that Lefluartil has been sufficiently eliminated from your body, and then you should wait at least 1 month before becoming pregnant.
For more information on laboratory tests, contact your doctor.
If you suspect that you may be pregnant during treatment with Lefluartil or in the 2 years following treatment, you should immediatelycontact your doctor for a pregnancy test. If the test confirms that you are pregnant, your doctor may suggest that you start treatment with certain medicines to accelerate the elimination of Lefluartil from your body, thereby reducing the risk to your child.
Do not takeLefluartil while breastfeeding, as leflunomide passes into breast milk.
Driving and using machines
Lefluartil may make you feel dizzy, which can affect your ability to concentrate and react. If this happens, do not drive or use machines.
Important information about some of the ingredients of Lefluartil
Lefluartil contains . If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine
Always take Lefluartil exactly as your doctor has told you. Consult your doctor or pharmacist if you have any doubts.
The usual initial dose of Lefluartil is 100 mg once a day for the first three days. After this, most people need a dose of:
For psoriatic arthritis: 20 mg of Lefluartil once a day.
Swallow the tablet whole and with plenty of water.
It may take about 4 weeks or even longer before you start to feel an improvement in your condition. Some patients may even notice a new improvement after 4 or 6 months of treatment. In general, Lefluartil should be taken for prolonged periods of time.
If you take more Lefluartil than you should
If you take more Lefluartil than you should, consult your doctor or any other healthcare service. If possible, take the tablets or the box to show the doctor.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Lefluartil
If you forget to take a dose, take it as soon as you remember, unless it is almost time for the next dose. Do not take a double dose to make up for the forgotten dose.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medicines, Lefluartil can cause side effects, although not everybody gets them.
Tell your doctor immediatelyand stop taking Lefluartil:
if you get skin rashesor mouth ulcers, as they may indicate serious reactions that can be life-threatening (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme).
Tell your doctor immediatelyif you experience:
any symptom of infectionsuch as fever, sore throat, or cough, as Lefluartil may increase the risk of serious infections that can be life-threatening,
Common side effects (affecting between 1 and 10 people in 100)
increase in blood levels of certain enzymes (creatine phosphokinase).
Uncommon side effects (affecting between 1 and 10 people in 1,000)
Rare side effects (affecting between 1 and 10 people in 10,000)
Very rare side effects (affecting less than 1 person in 10,000)
Other side effects such as kidney failure, decrease in uric acid levels in the blood, pulmonary hypertension, male infertility (this effect is reversible after stopping treatment with Lefluartil) may occur with unknown frequency.
If you think any of the side effects you are experiencing is serious or if you notice any side effects not listed in this leaflet, tell your doctor or pharmacist.
Keep out of the reach and sight of children.
Do not use Lefluartil tablets after the expiry date stated on the carton. The expiry date is the last day of the month shown.
Store in the original package.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to your pharmacist. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Lefluartil 10 mg film-coated tablets EFG
leflunomida.
starch (corn starch 1500), povidone (E1201), crospovidone (E1202), colloidal anhydrous silica, magnesium
stearate (E470b) in the tablet core, as well as titanium dioxide (E171), lactose monohydrate, hypromellose
15cP (E464), macrogol 4000, hypromellose 3cP (E464) and hypromellose 50 cP (E464) in the coating.
Product Appearance and Packaging Content
Lefluartil is presented in the form of white, round, and biconvex film-coated tablets.
The tablets are packaged in blisters of 30 and 100 tablets.
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
ARAFARMA GROUP, S.A.
C/ Fray Gabriel de San Antonio, 6-10
Pol.Ind. del Henares
19180 Marchamalo (Guadalajara). Spain
Date of the Last Revision of this Leaflet:
July 2024
Detailed and updated information on this medication is available on the website of the Spanish Agency
for Medicines and Health Products (AEMPS) http://www.aemps.es/